Navigation Links
Forced evolution: Can we mutate viruses to death?
Date:11/10/2008

HOUSTON -- Nov. 10, 2008 -- It sounds like a science fiction movie: A killer contagion threatens the Earth, but scientists save the day with a designer drug that forces the virus to mutate itself out of existence. The killer disease? Still a fiction. The drug? It could become a reality thanks to a new study by Rice University bioengineers.

The study, which is available online and slated for publication in the journal Physical Review E, offers the most comprehensive mathematical analysis to date of the mechanisms that drive evolution in viruses and bacteria. Rather than focusing solely on random genetic mutations, as past analyses have, the study predicts exactly how evolution is affected by the exchange of entire genes and sets of genes.

"We wanted to focus more attention on the roles that recombination and horizontal gene transfer play in the evolution of viruses and bacteria," said bioengineer Michael Deem, the study's lead researcher. "So, we incorporated both into the leading models that are used to describe bacterial and viral evolution, and we derived exact solutions to the models."

The upshot is a newer, composite formula that more accurately captures what happens in real world evolution. Deem's co-authors on the study include Rice graduate student Enrique Muoz and longtime collaborator Jeong-Man Park, a physicist at the Catholic University of Korea in Bucheon.

In describing the new model, Deem drew an analogy to thermodynamics and discussed how a geneticist or drug designer could use the new formula in much the same way that an engineer might use thermodynamics formulas.

"Some of the properties that describe water are density, pressure and temperature," said Deem. "If you know any two of them, then you can predict any other one using thermodynamics.

"That's what we're doing here," he said. "If you know the recombination rate, mutation rate and fitness function, our formula can analytically predict the properties of the system. So, if you have recombination at a certain frequency, I can say exactly how much that helps or hurts the fitness of the population."

Deem, Rice's John W. Cox Professor in Biochemical and Genetic Engineering and professor of physics and astronomy, said the new model helps to better describe the evolutionary processes that occur in the real world, and it could be useful for doctors, drug designers and others who study how diseases evolve and how our immune systems react to that evolution.

One idea that was proposed about five years ago is "lethal mutagenesis." In a nutshell, the idea is to design drugs that speed up the mutation rates of viruses and push them beyond a threshold called a "phase transition." The thermodynamic analogy for this transition is the freezing or melting of water -- which amounts to a physical transition between water's liquid and solid phases.

"Water goes from a liquid to a solid at zero degrees Celsius under standard pressure, and you can represent that mathematically using thermodynamics," Deem said. "In our model, there's also a phase transition. If the mutation, recombination or horizontal gene transfer rates are too high, the system delocalizes and gets spread all over sequence space."

Deem said the new results predict which parameter values will lead to this delocalization.

A competing theory is that a mutagenesis drug may eradicate a virus or bacterial population by reducing the fitness to negative values. The new mathematical results allow calculation of this mechanism when the fitness function and the mutation, recombination and horizontal gene transfer rates are known.

Without theoretical tools like the new model, drug designers looking to create pills to induce lethal mutagenesis couldn't say for certain under what parameter ranges the drugs really worked. Deem said the new formula should provide experimental drug testers with a clear picture of whether the drugs -- or something else -- causes mutagenesis.


'/>"/>

Contact: Jade Boyd
jadeboyd@rice.edu
713-348-6778
Rice University
Source:Eurekalert

Related biology news :

1. A new method to identify mutated genes in human diseases
2. World leaders in infectious diseases convene to discuss emerging global viruses
3. Research about plant viruses could lead to new ways to improve crop yields
4. Structures of important plant viruses determined
5. Why some primates, but not humans, can live with immunodeficiency viruses and not progress to AIDS
6. Herpes drug inhibits HIV in patients infected with both viruses
7. Study reveals how viruses collectively decide the fate of a bacterial cell
8. Hebrew University study opening new route for combating viruses
9. Beaded viruses and geology-inspired paintings show the art in science
10. Scientists paint viruses to track their fate in the body
11. HIV infection stems from few viruses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016  The Office ... today published "Can CT Scans Enhance or Replace ... the potential of supporting or replacing forensic autopsies ... CT scan. In response to recommendations ... is exploring using CT scans as a potential ...
(Date:12/2/2016)... , Dec. 1, 2016   SoftServe , ... BioLock , an electrocardiogram (ECG) biosensor analysis ... a key IoT asset. The smart system ensures ... vehicle,s steering wheel and mobile devices to easily ... As vehicle technology advances, so too ...
(Date:11/30/2016)... , Nov. 30, 2016  higi SH ... new partnership initiative targeting national brands, industry thought-leaders ... reward their respective audiences for taking steps to ... its inception in 2012, higi has built the ... impacting over 38 million people who have conducted ...
Breaking Biology News(10 mins):
(Date:12/8/2016)... Dec. 8, 2016  Renova™ Therapeutics, a biotechnology ... failure and type 2 diabetes, announced that it ... adeno-associated virus (AAV) vector developed in the laboratory ... at Stanford University. The company plans to use ... therapy product pipeline. "Early research ...
(Date:12/8/2016)... Oxford Gene Technology (OGT), ... panel range with the launch of the SureSeq myPanel™ NGS ... variants in familial hypercholesterolemia (FH). The panel delivers single nucleotide ... single small panel and allows customisation by ,mix and match, ... for LDLR , P C SK9 ...
(Date:12/8/2016)... ... December 08, 2016 , ... This CAST literature review and report looks at ... focus on the economic effects in countries that are major global commodity exporters and ... the resultant risk of low level presence (LLP) puts large volumes of trade worth ...
(Date:12/8/2016)... 8, 2016 Eutilex Co. Ltd. today announced ... $18.9M) Series A financing. This financing round included participation ... and SNU Bio Angel. This new funding brings the ... (US $27.7M) since its founding in 2015. ... development and commercialization of its immuno-oncology programs, expand its ...
Breaking Biology Technology: